Skip to main content
Egyptian Rheumatology and Rehabilitation

Table 4 Anxiety “Hamilton Anxiety Rating Scale” in SLE patients during COVID-19 outbreak

From: Hydroxychloroquine non-availability during COVID-19 pandemic and its relation to anxiety level and disease activity in rheumatoid arthritis and lupus patients: a cross-sectional study

 

With HCQ shortage (76)

Without HCQ shortage (28)

P value

Anxiety level

28.61 ± 10.83

22.11 ± 9.57

0.0058*

Mild

5 (6.6%)

8 (28.6%)

0.006*

Mild to moderate

22 (28.9%)

11 (39.3%)

Moderate to severe

33 (43.4%)

6 (21.4%)

Severe

16 (21.1%)

3 (10.7%)

  1. SLE systemic lupus erythematosus, HCQ hydroxychloroquine
  2. *Significant P value if p < 0.05
Back to article page